Abstract
Thyroid cancer (TC) is the most prevalent endocrine-related malignancy. Significant breakthroughs in studying TC have provided a deeper understanding of the factors that either support or impede the effectiveness of therapy and control methods. Some significant biomarker breakthroughs have resulted in a more precise knowledge of the pathways responsible for TC. This chapter focuses mainly on the biomarker breakthroughs that have occurred in the detection and management of TC as well as the potential implications that these biomarkers may have for future advancements aimed at improving the detection and management of TC.
| Original language | English |
|---|---|
| Title of host publication | Biomarker Landscape in Cancer Research |
| Publisher | Elsevier |
| Pages | 269-290 |
| Number of pages | 22 |
| ISBN (Electronic) | 9780443339028 |
| ISBN (Print) | 9780443339035 |
| DOIs | |
| Publication status | Published - 1 Jan 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Biomarkers
- Calcitonin
- Immunoassay
- Metabolomics
- Midkine
- Signaling
- Thyroglobin
- Thyroid cancer
Fingerprint
Dive into the research topics of 'Thyroid cancer: Biomarker landscape'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver